Prelude Capital Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,228
Closed -$619K 1174
2023
Q2
$619K Buy
15,228
+6,939
+84% +$282K 0.04% 338
2023
Q1
$402K Buy
+8,289
New +$402K 0.02% 468
2022
Q4
Sell
-4,609
Closed -$231K 1421
2022
Q3
$231K Buy
+4,609
New +$231K 0.01% 989
2020
Q4
Sell
-1,300
Closed -$61K 1378
2020
Q3
$61K Sell
1,300
-7,531
-85% -$353K ﹤0.01% 816
2020
Q2
$448K Buy
8,831
+4,856
+122% +$246K 0.02% 301
2020
Q1
$177K Sell
3,975
-26,192
-87% -$1.17M 0.01% 268
2019
Q4
$1.45M Buy
30,167
+29,757
+7,258% +$1.43M 0.06% 118
2019
Q3
$14K Sell
410
-44,163
-99% -$1.51M ﹤0.01% 980
2019
Q2
$2.01M Buy
44,573
+23,968
+116% +$1.08M 0.1% 96
2019
Q1
$776K Buy
+20,605
New +$776K 0.04% 203
2018
Q4
Sell
-78,071
Closed -$3.67M 1677
2018
Q3
$3.67M Sell
78,071
-25,888
-25% -$1.22M 0.21% 56
2018
Q2
$3.51M Sell
103,959
-65,004
-38% -$2.19M 0.22% 54
2018
Q1
$4.57M Sell
168,963
-119,506
-41% -$3.23M 0.33% 44
2017
Q4
$4.81M Buy
288,469
+107,090
+59% +$1.79M 0.39% 41
2017
Q3
$3.63M Sell
181,379
-100,845
-36% -$2.02M 0.33% 56
2017
Q2
$5.17M Sell
282,224
-13,971
-5% -$256K 0.49% 41
2017
Q1
$2.92M Buy
296,195
+115,171
+64% +$1.13M 0.28% 67
2016
Q4
$1.98M Sell
181,024
-34,947
-16% -$381K 0.24% 110
2016
Q3
$3.03M Buy
215,971
+207,171
+2,354% +$2.9M 0.32% 50
2016
Q2
$62K Buy
+8,800
New +$62K 0.01% 879
2015
Q4
Sell
-5,737
Closed -$153K 1557
2015
Q3
$153K Buy
5,737
+5,037
+720% +$134K 0.02% 640
2015
Q2
$34K Buy
+700
New +$34K ﹤0.01% 1163